B. Riley Financial, Inc. Enanta Pharmaceuticals Inc Transaction History
B. Riley Financial, Inc.
- $109 Million
- Q4 2024
A detailed history of B. Riley Financial, Inc. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, B. Riley Financial, Inc. holds 10,000 shares of ENTA stock, worth $58,600. This represents 0.24% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$58,600% of portfolio
0.24%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
107Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$12.4 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$12.4 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$11.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$10.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$7.16 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $121M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...